Teva Pharmaceuticals USA is recalling approximately 17,436 bottles of Methylphenidate hydrochloride Extended-Release tablets (the generic version of Concerta), including both 18 mg and 27 mg strengths. The recall was initiated because some bottles may be missing the desiccant—a small packet used to keep the medication dry. Without the desiccant, moisture can degrade the tablets, potentially affecting how well the medication works over time.
The absence of a desiccant in the product bottle can lead to moisture absorption, which may cause the medication to break down or lose its effectiveness before the expiration date. This could result in patients receiving an insufficient dose of their medication.
Drug recall guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.